SCHEMBL29349682

SCHEMBL29349682

O=C(N1CC2CC(C1)c1cc3nccnc3cc12)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.45
CHRNB4 P30926 2/20 0.45
CHRNA3 P32297 2/20 0.45
CHRNA1 P02708 1/20 0.45
CHRNG P07510 1/20 0.45
CHRNB1 P11230 1/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNA5 P30532 1/20 0.45
CHRNA7 P36544 1/20 0.45
CHRNA4 P43681 1/20 0.45
HTR3A P46098 1/20 0.45
CHRND Q07001 1/20 0.45
CHRNA2 Q15822 1/20 0.45
HPGD P15428 1/20 0.35
ESR2 Q92731 2/20 0.35
ECE2 P0DPD6 1/20 0.34
HPGDS O60760 1/20 0.33
RBP4 P02753 1/20 0.33
PROKR1 Q8TCW9 4/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13561413 1.00 ESR1 (0.45) ESR1CHRNB4CHRNA3CHRNA1CHRNG
SCHEMBL224375 1.00 ESR1 (0.45) ESR1CHRNB4CHRNA3CHRNA1CHRNG
SCHEMBL25402074 0.84 RBP4 (0.36) CHRNB2CHRNA4HPGDSRBP4PROKR1
SCHEMBL29761235 0.84 RBP4 (0.36) CHRNB2CHRNA4HPGDSRBP4PROKR1
SCHEMBL25951618 0.83 CHRNB2 (0.51) ESR1CHRNB4CHRNA3CHRNA1CHRNG
SCHEMBL8205378 0.81 CHRNB2 (0.50) ESR1CHRNB4CHRNA3CHRNA1CHRNG
SCHEMBL14003852 0.81 CHRNB2 (0.53) ESR1CHRNB2CHRNA4HPGDESR2
SCHEMBL225881 0.81 CHRNB2 (0.53) ESR1CHRNB2CHRNA4HPGDESR2
SCHEMBL225186 0.80 ESR1 (0.37) ESR1ESR2HPGDSRBP4PROKR1
SCHEMBL4689632 0.80 CHRNB2 (0.41) ESR1CHRNB2CHRNA4HPGDESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113956255-A Preparation method of varenicline intermediate, varenicline and salt thereof 威智医药有限公司 2022-01-21 CN disclosed